BupropionQTc Prolongation following off label treatment: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1894卷 / 1期

关键词：

D O I：

10.1007/s40278-022-10197-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：84 / 84

相关论文

共 50 条

[21] MethylprednisoloneStrongyloidiasis following off-label treatment: case report
[J]. Reactions Weekly, 2022, 1893 (1) : 213 - 213
[22] HydroxychloroquineBorderline prolongation of QTc interval during off-label treatment: case report
[J]. Reactions Weekly, 2020, 1829 (1) : 195 - 195
[23] BupropionQTc interval prolongation and tachyarrhythmia due to oral intoxication : case report
[J]. Reactions Weekly, 2023, 1966 (1) : 101 - 101
[24] HydroxychloroquineElectrical storm and QT interval prolongation following off-label use: case report
[J]. Reactions Weekly, 2020, 1834 (1) : 125 - 125
[25] HydroxychloroquineRight bundle branch block and QTc prolongation following off label use: case report
[J]. Reactions Weekly, 2020, 1817 (1) : 167 - 167
[26] Azithromycin/hydroxychloroquineCorrected QT-interval prolongation following off label use: case report
[J]. Reactions Weekly, 2020, 1823 (1) : 91 - 91
[27] Azithromycin/hydroxychloroquine interactionQT interval prolongation following off-label use: case report
[J]. Reactions Weekly, 2020, 1818 (1) : 54 - 54
[28] DexamethasoneLack of efficacy following an off-label treatment: case report
[J]. Reactions Weekly, 2022, 1929 (1) : 244 - 244
[29] FavipiravirLack of efficacy following off-label treatment: case report
[J]. Reactions Weekly, 2021, 1879 (1) : 155 - 155
[30] CannabidiolVarious toxicities following off-label treatment: case report
[J]. Reactions Weekly, 2021, 1860 (1) : 103 - 103

← 1 2 3 4 5 →